Information Library
Results for: Case Studies - Infectious Diseases - Enrollment & retention
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Off-Season Pediatric Enrollment
June 24, 2011
This sponsor needed to conduct a pediatric influenza during the off-season months of March - May. Quintiles completed enrollment and database lock ahead of schedule. -
Malaria Prevention in Sub-Saharan Africa
June 24, 2011
This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands -
H1N1 - Proactive Engagement
February 1, 2011
Despite short timelines and government requirements, an H1N1 vaccine study finished in time for the influenza season. -
Promoting Prevention
February 1, 2011
How do you recruit for an influenza vaccine trial off-season? Quintiles tapped our Partner Sites and completed enrollment in just four days. -
Advancing Prevention in Korea
September 14, 2010
The original recruitment target and timeline were met with more than 1,100 patients screened to yield 420 randomized patients. -
Propelling Pediatric Research
April 1, 2010
Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study -
Boosting Pediatric Enrollment
April 1, 2010
Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks. -
The Right Balance
March 31, 2010
Through creative strategies and proactive measures, learn how Quintiles achieved both the recruitment targets and database lock eight months early. -
Hepatitis B Vaccine-Successful Study Strategy in Asia
November 9, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia. -
Nasal Influenza Vaccine
September 22, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a nasal influenza vaccine study in Argentina, Brazil and South Africa.
